Popular
The Real Drivers of This Market: AI, Semis...
Week Ahead: NIFTY Violates Short-Term Supports; Stays Tentative...
The Best Five Sectors, #28
Tech 5: TSMC, ASML Release Latest Results, NVIDIA...
Three Stocks in Focus: One Old Favorite, One...
July Strength, Late-Summer Caution: 3 Charts to Watch
The Real Drivers of This Market: AI, Semis...
Editor’s Picks: Silver Price Breaks US$39 Again, Rare...
Canadian Investment Regulatory Organization Trade Resumption – PRIZ
What Was the Highest Price for Copper?
  • Home
HotInvestingPilots.com
  • Politics
  • World News
  • Stock
  • Investing
Politics

8-Year-Old Boy in Peru Develops ‘Stevens-Johnson Syndrome’ Following Second Dose of Pfizer Covid-19

by March 16, 2022
written by March 16, 2022

An 8-year-old boy from Bongará, Peru was diagnosed with ‘Stevens-Johnson Syndrome’ days after receiving his second dose of Pfizer Covid-19 vaccine.

Richard Jeferson Bustamante Bautista suffered a horrific adverse reaction reportedly due to the Pfizer vaccine.

According to his vaccination card, Richard Jeferson Bustamante Bautista, received his first dose of vaccine last January 30, 2022, and got his second dose on February 21, 2022.

Days after receiving his second dose, he developed “Stevens-Johnson Syndrome.”

“Stevens-Johnson syndrome (SJS) is a rare, serious disorder of the skin and mucous membranes. It’s usually a reaction to medication that starts with flu-like symptoms, followed by a painful rash that spreads and blisters,” per Mayo Clinic.

Via Covid Vaccine Injuries [Translated]:

He had a reaction three days after his 2nd Pfizer dose. He had hives all over his body and has been in two different hospitals since. He’s currently in a children’s hospital in Lima, being treated in the burn unit for his skin condition.

He is progressively getting worse.

The father didn’t know the vaccine was experimental and was all but forced into giving it to his son as there was the threat of him not being able to attend classes without it.

His sight is suffering and he needs an operation currently because he cannot urinate.

Warning: SENSITIVE PHOTO

Eight-year-old Richard Jeferson Bustamante Bautista received the first dose on January 30, 2022 and the second dose on February 21, 2022, both with Pfizer.

A few days later he developed “Stevens-Johnson Syndrome” pic.twitter.com/3JFbTdjxaH

— 3 (@M_T_L514) February 28, 2022

“Stevens-Johnson syndrome (SJS) is a rare, serious disorder of the skin and mucous membranes. It’s usually a reaction to medication that starts with flu-like symptoms, followed by a painful rash that spreads and blisters,” per Mayo Clinic.

A case report was published on the NIH website about “Stevens-Johnson syndrome post-second dose of Pfizer COVID-19 vaccine.”

The study reported, “one potential complication of the Pfizer COVID-19 vaccine: a known case of Stevens-Johnson syndrome (SJS) that occurred after the second dose of the Pfizer COVID-19 vaccine alone without exposure to any other drug. Despite the initial severe adverse reaction, the patient showed a full recovery. Although SJS can be associated with COVID-19 vaccination, it is rare, and the benefits of receiving the vaccination outweigh the potential harms.”

Another incident was published on the NIH website about a 60-year-old man suffering SJS after the first dose of the Covid-19 vaccine.

“Steven-Johnson syndrome (SJS) is a severe cutaneous adverse drug reaction. Its occurrence due to vaccines is scant. We report a case of SJS caused by COVID-19 vaccine in an adult,” the study stated.

“A 60-year-old male presented with complaints of fever, oral ulceration, and skin rash three days after the first dose of COVID‐19 vaccine, for which he visited a local physician and was prescribed paracetamol and levocetrizine, inspite of which the symptoms were not controlled and gradually the rashes became generalized in distribution,” according to the abstract of the case report.

 

The post 8-Year-Old Boy in Peru Develops ‘Stevens-Johnson Syndrome’ Following Second Dose of Pfizer Covid-19 appeared first on The Gateway Pundit.

0 comment
0
FacebookTwitterPinterestEmail

previous post
China lockdowns may delay orders from online platforms
next post
LIVE-STREAM VIDEO: Ukrainian President Volodymyr Zelenskyy Addresses Full US Congress in Virtual Address Starting at 9 AM ET

Related Articles

Early voting in Wisconsin slowed by label printing...

October 24, 2024

American creating deepfakes targeting Harris works with Russian...

October 24, 2024

A GOP operative accused a monastery of voter...

October 24, 2024

Tucker Carlson says father Trump will give ‘spanking’...

October 24, 2024

Trump’s exaggerated claim that Pennsylvania has 500,000 fracking...

October 24, 2024

Biden spurs controversy by saying ‘We’ve got to...

October 23, 2024

McDonald’s where Trump served fries hit with flurry...

October 23, 2024

In close race that could tip House, candidates...

October 23, 2024

As Democratic icons stump for Harris, GOP elders...

October 23, 2024

Past Trump advisers say he’s fascist. Trump says...

October 23, 2024

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Recent Posts

  • The Real Drivers of This Market: AI, Semis & Robotics

    July 20, 2025
  • Week Ahead: NIFTY Violates Short-Term Supports; Stays Tentative Devoid Of Any Major Triggers

    July 20, 2025
  • The Best Five Sectors, #28

    July 20, 2025
  • Tech 5: TSMC, ASML Release Latest Results, NVIDIA to Resume Sales to China

    July 20, 2025
  • Three Stocks in Focus: One Old Favorite, One Mag Name, and a Dow Comeback Story

    July 19, 2025
  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 hotinvestingpilots.com | All Rights Reserved

HotInvestingPilots.com
  • Politics
  • World News
  • Stock
  • Investing